As a global company, COVID-19 has impacted every part of Jabil. Through it all, our main priority has been keeping our employees healthy.

At the very start of the COVID-19 pandemic crisis, Jabil sprang into action. Protective measures were established initially at our operating China sites, including hygiene protocols, temperature screenings and sanitation stations, as well as limiting plant access to only essential manufacturing employees. Business travel was restricted, and eligible employees worked from home to minimize the spread and impact of the virus. Established quarantine and tracing protocols were put in place for suspected cases. These protocols and best practices were quickly implemented at sites around the world when COVID-19 continued to spread.

In addition to taking extensive proactive measures to protect our employees, we retooled and ramped numerous production facilities to help meet the growing equipment needs of hospitals and workers.

As PPE supplies grew increasingly limited around the world, our teams came up with a solution: They’d make their own hand sanitizer and face masks. At the height of the pandemic during 2020 and 2021, Jabil and its medical device subsidiary, NP Medical, were producing more than a million FDA-cleared, Berry Amendment-compliant surgical face masks each week at sites across the United States.

Jabil’s efforts to fight COVID-19 reached beyond the company and into our communities. Sites in Tortosa, Spain, and Auburn Hills, United States, used their 3D printing capabilities to create face shield headbands and respirator parts for hospitals treating COVID-19 patients. Our site in Manaus, Brazil, even used the funds they were awarded from our internal continuous improvement competition, Deliver Best Practices, to donate over 1,000 pounds of food to an elderly shelter and masks to a blood disease hospital.

Jabil strongly encouraged all employees to get the COVID-19 vaccine as it became available. We have shared educational information with all our sites to elevate trust and confidence in the vaccine and partnered with local health authorities to help employees get vaccinated at sites around the globe. In Malayasia, Jabil’s Penang Vaccination Center completed the two-dose vaccine regiment for over 14,000 Jabil employees and frontline workers of more than 100 partner companies by August 2021.

With our global manufacturing capacity, we helped our customers accelerate the time-to-market for COVID-19 tests and rapidly ramped production of desperately needed medical devices like pulse oximeters and respirators. Of the latter, Jabil successfully scaled production from 2,000 to 40,000 respirators a year.

More People & Communities Stories